Advertisement

Orthofix Medical Inc. OFIX

Set alert

Price alert · OFIX

All alert types
9.07 USD -1.17 -11.43%

At close · Oct 30

9.07 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
9.07 × 2
Ask
9.08 × 2
8.90 Day range 10.29
8.64 52-week range 16.20
YTD
-40.17%
1 year
-41.37%
Open
10.29
Prev close
10.24
Mkt cap
366.62M
Vol
657.86K
Avg vol
381.89K
EPS
-1.52
P/E
0.00
Div yield
0.00%
More statistics
Low
8.90
High
10.29
Forward P/E
-1733.00
Beta
1.05
Short ratio
3.89
Inst. own
92.27%
Dividend
0.00
Ex-div date
50-d avg
17.72
200-d avg
15.53
1y target
24.40

3M chart

Chart tools
Interval

Signals (19)
NameDateAgo
SMA: BearishOct 30, 20261 day ago
SMA: BearishOct 30, 20261 day ago
SMA: BullishOct 19, 20261 week ago
SMA: BearishOct 16, 20262 weeks ago
SMA: BullishOct 15, 20262 weeks ago
SMA: BullishOct 12, 20262 weeks ago
SMA: BearishOct 7, 20263 weeks ago
SMA: BullishOct 5, 20263 weeks ago
SMA: BearishOct 1, 20261 month ago
SMA: BullishSep 25, 20261 month ago
MACD: Buy SignalSep 21, 20261 month ago
MACD: Sell SignalSep 17, 20261 month ago
MACD: Buy SignalSep 16, 20261 month ago
RSI: OversoldSep 9, 20261 month ago
SMA: BearishAug 7, 20262 months ago
SMA: BullishAug 6, 20262 months ago
SMA: BearishAug 5, 20262 months ago
SMA: BearishAug 5, 20262 months ago
MACD: Sell SignalAug 5, 20262 months ago

Key statistics

Market cap
662.25M
Enterprise value
792.19M
Trailing P/E
0.00
Forward P/E
-1733.00
PEG ratio
0.00
Price / sales
0.84
Price / book
1.26
EPS (TTM)
-3.14
Beta
1.05
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-15.18%
Revenue (TTM)
784.25M
Revenue growth
6.80%
Free cash flow
25.91M
Total cash
30.05M
Total debt
156.17M
Return on equity
-20.86%
Shares outstanding
38.21M
Short % of float
3.69%
50-day average
17.72
200-day average
15.53

Analyst view

Consensus: none

Price target (mean) 24.40 +169.0% upside
Target (low)
22.00
Target (mean)
24.40
Target (high)
27.20
Ratings (0m) 5 3 buy · 2 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.05.

Earnings history

Financials — quick view

All financials
OFIX Revenue — quarterly 210.93M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OFIX Net income — quarterly -15.80M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
OFIX EPS — quarterly -0.39
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

OFIX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.140.07+0.21+150.00%
Aug 6, 2024Jun 1, 2024-0.130.05+0.18+138.46%
May 7, 2024Mar 1, 2024-0.32-0.46-0.14-43.75%
Mar 5, 2024Dec 1, 2023-0.14-0.10+0.04+28.57%
Nov 8, 2023Sep 1, 2023-0.220.07+0.29+131.82%
Aug 8, 2023Jun 1, 2023-0.670.02+0.69+102.99%

Upgrades / downgrades

OFIX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 8, 2024Roth MKMreitBuyBuy
Nov 8, 2024StifelupHoldBuy
May 8, 2024Roth MKMupNeutralBuy
Apr 22, 2024JMP Securitiesreit—Market Perform
Mar 7, 2024Roth MKMmainNeutralNeutral
Oct 20, 2023Roth MKMinit—Neutral

About Orthofix Medical Inc.

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
orthofix.com

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on OFIX — it syncs with the Stock Master app.

Insider holders

OFIX insider holders
InsiderRelationLatest transactionDateShares held
BAZAAR ALAN LEEDirectorStock Award(Grant)Jun 17, 202424,088
BURRIS WAYNE C.DirectorStock Award(Grant)Jun 17, 202431,698
FINEGAN MICHAEL MDirectorStock Award(Grant)Jun 17, 202429,718
FISHER PATRICK GOfficerStock Award(Grant)Aug 14, 202415,319
GILLESPIE GEOFFREY C.OfficerSaleDec 16, 202441,041
HANNON JASON MDirectorStock Award(Grant)Jun 17, 202449,364

Institution ownership

OFIX institution ownership
Holder% heldSharesValueReported
Armistice Capital, LLC9.86%3,768,00065.30MSep 29, 2024
Rubric Capital Management LP9.67%3,694,94664.03MSep 29, 2024
Engine Capital Management, LP8.82%3,368,66558.38MSep 29, 2024
Blackrock Inc.8.19%3,130,01854.24MSep 29, 2024
Paradigm Capital Management6.69%2,556,50044.30MSep 29, 2024
Vanguard Group Inc5.53%2,114,49936.64MSep 29, 2024

Fund ownership

OFIX fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.94%1,123,23519.47MSep 29, 2024
iShares Russell 2000 ETF2.23%852,28814.77MOct 30, 2024
Vanguard Extended Market Index Fund1.54%587,49210.18MSep 29, 2024
Fidelity Small Cap Index Fund0.90%344,5285.97MAug 30, 2024
Paradigm Micro Cap Fund0.89%340,0005.89MSep 29, 2024
iShares Russell 2000 Value ETF0.84%320,6165.56MOct 30, 2024
Advertisement